Mode
Text Size
Log in / Sign up
N/A N=97 Randomized Single-blind Treatment

Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation

Interstitial Cystitis

Enrolled (actual)
97
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Number of Participants Designated as "Treatment Responders" Based on Global Response Assessment (GRA) — 31; 10 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Treatment (Behavioral); Usual Cares (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
University of New Mexico
Primary completion
Sep 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Designated as "Treatment Responders" Based on Global Response Assessment (GRA)
31; 10
SECONDARY
O'Leary-Sant: Interstitial Cystitis Symptom Index
-3.4; -1.5
SECONDARY
O'Leary-Sant: Interstitial Cystitis Problem Index
-3.7; -1.9
SECONDARY
Pain VAS Score
-1.7; -0.3
SECONDARY
Hospital Anxiety and Depression Scale (HADS) Anxiety Subscale
-1.6; -0.6
SECONDARY
Hospital Anxiety and Depression Scale (HADS) Depression Subscale
-1.6; -0.7
SECONDARY
PROMIS Pain Interference Score
-5.5; -3.1
SECONDARY
Pain Self-efficacy-2 Score
1.5; 0.9

Summary

This study is examining impact of pain on daily life, the ability to function and treatments used for patients with interstitial cystitis/painful bladder syndrome before and after a program of mindfulness and yoga, in comparison to patients who are undergoing treatment with their providers.

Eligibility Criteria

Inclusion Criteria

  • Female
  • >=Age 18
  • IC/BPS diagnosis
  • English or Spanish reading/writing
  • Own a Smartphone and able to watch online yoga tutorials
  • Ability/willingness to participate in follow up questionnaires
  • ICSI/ICPI >6 at baseline
  • Physical exam in the past 2 years by urogynecology or gynecologist

Exclusion Criteria

  • Pregnancy or lactating
  • Inability to speak/write in English/Spanish
  • Known history of recurrent UTI
  • Urinary retention ( PVR>150 ml)
  • History of augmentation cystoplasty or urinary diversion.
  • History of chemotherapy/radiation or radiation induced cystitis
  • Hunner's Ulcers demonstrated in last 6 months by cystoscopy
  • Parkinsonism with neurogenic bladder
  • Multiple Sclerosis with neurogenic bladder
  • CVA with residual deficits
  • Patients with severe mobility impairment and inability to perform yoga postures
  • Patients who are hard of hearing or visually impaired
  • Imprisoned patients
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04820855). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search